With a market cap of $23.3 billion, Labcorp Holdings Inc. (LH) is a global life sciences and healthcare company. The North Carolina-based company helps physicians, hospitals, biopharmaceutical companies, researchers, and patients by delivering diagnostic testing, clinical trial support, and laboratory services that aid disease detection, treatment decisions, and the development of new medicines.
The global leader of innovative and comprehensive laboratory services is expected to announce its second-quarter earnings on Thursday, July 30, 2026 before the market opens. Ahead of the event, analysts expect LH to report a profit of $4.79 per share on a diluted basis, up 10.1% from $4.35 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.